Found "Early HTA": 383 results
The dissemination of the information concerning human papillomavirus (HPV) vaccine via printing media in thailand and the effect of these information for knowledge, attitude and vaccination decision among women in thailand (in Thai language)
This study aims to review public information concerning Human papillomavirus (HPV) vaccine that was disseminated through printing media in Thailand. It also examines the knowledge and decision to get vaccinated among people who had exposed and not exposed to the information. Media analysis was performed on articles published in popular health, wome
School-Based Screening for Attention Deficit and Hyperactivity Disorder (ADHD) and Learning Disorders (LD) (in Thai language)
Attention Deficit and Hyperactivity Disorder (ADHD) is one of the health problems that affect learning, behavior, child development and sociability of school children. If ADHD is detected early and the correct treatment is provided, a patient can recover from the disease and live a normal life. ADHD screening measures currently used have diversity
Social Costs of Tobacco and Alcohol in Sri Lanka
To develop Health Intervention and Technology Assessment (HITA) capacity in member states, World Health Organization, South East Asia Regional Office (WHO SEARO) allocated funding for HITA capacity building in the region. Sri Lanka, together with Indonesia and Nepal, was selected to be a country case study. The project began in early 2015 and is pa
Strengthen Capacity for Infectious Diseases Modelling in Thailand and Supporting the Use of Evidence to Respond to Pandemics Across the Asian Region and LMICs
Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions. The
Development of reference case for economic evaluation on precision medicine for health insurance reimbursement in Thailand
The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve
Limited resources and cutting-edge technology infiltrating every role mark the beginning of the health prioritization at the “Priorities 2024 Conference.
May 8 – 10, 2024 – the Ministry of Public Health, by the Health Intervention Technology Assessment Thailand (HITAP), partnered with the International Society for Priorities in Health (ISPH), a network of researchers, medical professionals, and policy-makers working in health prioritization, to organ
Knowledge Translation: The Key to Turning Mathematical Models from a Black Box into a Powerful Tool for Policy Decision-Making (Part 1) — How Mathematical Modeling Supports Public Health—and Why It’s Not Enough
This article is part 1 of the blog series: “Knowledge Translation: The Key to Turning Mathematical Models from a Black Box into a Powerful Tool for Policy Decision-Making”
As health systems become more complex, decision-makers need tools that can help them evaluate long-term outcomes and choose
Gao Qi
Gao Qi is a research assistant at Saw Swee Hock School of Public Health, National University of Singapore in collaboration with MIDAS. Research fields include framework construction of health innovation process, early health technology assessment, and traditional health technology assessment. Interested in health policy effects and health innovatio
Dr. Arpaporn Sutipatanasomboon
Dr. Arpaporn Sutipatanasomboon is experienced in cell biology and molecular genetics research and is a registered patent agent with the Thailand Department of Intellectual Property. Her passion is to integrate early health technology assessment and intellectual property management to support decision makers, innovators and promote access to innovat
Dr. Teerawat Wiwatpanit
Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti
10 / Page